Chemical Compound
(1R,2R,4S)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl dimethylphosphinate
CAS Registry Number
572924-54-0
Primary record
(1R,2R,4S)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl dimethylphosphinate
- 库存
- 1,996 克
- 纯度
- 99.6 %
- CAS
- 572924-54-0
化合物标识与属性
- CAS
- 572924-54-0
- PubChem CID
- 11520894
- SMILES
- C[C@@H]1CC[C@H]2C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C(=O)[C@@H]([C@@H](/C(=C/[C@H](C(=O)C[C@H](OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@@]1(O2)O)[C@H](C)C[C@@H]4CC[C@H]([C@@H](C4)OC)OP(=O)(C)C)C)/C)O)OC)C)C)/C)OC
- Canonical SMILES
- CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C
名称与同义词
- Ridaforolimus
- Deforolimus
- Taltorvic
- jenzyl
- ridaforolimusum
- 42- rapamycin
- AP23573
- MK-8669
- Ridaforolimus, >80%
- 572924-54-0
- Ridaforolimus [USAN]
- Unable to generate value
- RefChem:179414
- RIDAFOROLIMUS [MI]
- RIDAFOROLIMUS [INN]
- RIDAFOROLIMUS [JAN]
- Deforolimus (MK-8669)
- Ridaforolimus [USAN:INN]
- AP-23573
- 48Z35KB15K
- MK8669
- Ridaforolimus (MK-8669)
- RIDAFOROLIMUS [MART.]
- UNII-48Z35KB15K
- RIDAFOROLIMUS [WHO-DD]
- DTXSID001025942
- GTPL7884
- orb1300859
- CHEMBL2103839
- C53H84NO14P
- CHEBI:82677
- L01XE19
- Rapamycin, 42-(dimethylphosphinate)
- 42-(Dimethylphosphinate)rapamycin
- DTXCID401510193
- GLXC-08062
- MK 8669
- MFCD13184816
- NSC757440
- s1022
- AP 23573
- AKOS030526165
- ZINC169677038
- CCG-270602
- CS-0122
- DB06233
- NSC-757440
- RL04162
- SDCCGSBI-0654328.P001
- Ridaforolimus (Deforolimus, MK-8669)
- NCGC00346481-02
- FD111870
- HY-50908
- SY274066
- B1639
- Rapamycin, 42-?(dimethylphosphinate?) (9CI)
- W-5561
- Deforolimus,Ridaforolimus, AP23573, MK-8669
- 924D540
- Q2151796
- BRD-K62304154-001-03-4
- BRD-K62304154-001-04-2
- (1R,2R,4S)-4-((R)-2-((3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-Dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1]oxa[4]azacyclohentriacontin-3-yl)propyl)-2-methoxycyclohexyl dimethylphosphinate
- Deforolimus|||AP-23573|||MK-8669|||Rapamycin 42-(dimethylphosphinate)
- Rapamycin, 42-(dimethylphosphinate) (9CI); AP 23573; Deforolimus; MK 8669; Ridaforolimus
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-((1R)-2- ((1S,3R,4R)-4-((Dimethylphosphinoyl)oxy)-3-methoxycyclohexyl)-1-methylethyl)-1,18- dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4- azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene- 2,3,10,14,20-pentone
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-((2R)-1-((1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl)propan-2-yl)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
- 682-462-9